Literature DB >> 3840730

Adult hypophosphatemic osteomalacia: report of two cases.

H Rico, F Gomez-Castresana, E R Hernandez, J A Matute, J Torrubiano, M Nunez-Torrón.   

Abstract

Two cases of late hypophosphatemic osteomalacia are described: a male aged 30 who had the disease since he was 22 and a woman of 23 who had the disease since she was 14. Both presented with myopathy and bone pain, and showed hypophosphatemia, hyperglycinuria, reduced tubular phosphate reabsorption (TPR), increased hydroxyprolinuria and normal iPTH and iCT values. Radiologically the male had no Looser's zones and the woman did. Bone biopsy confirmed hypophosphatemic osteomalacia. Both cases were treated with vitamin D and oral phosphate and no improvement was observed. When treatment with 25(OH)D3 was initiated, no improvement was seen and afterwards this was combined with treatment using 1.25(OH)2D3 and from this time on a clinical improvement of the myopathy became evident in both patients. In the woman, healing of the bone lesions occurred at the same time as that of the myopathy, whereas in the male the bone lesions became worse. Healing of the myopathy was only obtained when treatment with 1.25(OH)2D3 was begun. Both patients had reduced values of 2.3 erythrocytic DPG and low level of serum phosphorus when the myopathy was cured, which suggests a lack of effect of 2.3 DPG or serum phosphorus as a cause of the myopathy. Although this had been attributed to a deficiency in the function of 25(OH)D3, the response to 1.25(OH)2D3 and due to the effects of this metabolite on calcium transport in muscle, suggests that the myopathy which occurs in late hypophosphatemic osteomalacia is a result of deficiency or resistance to the muscular effect of this metabolite. We cannot explain the lack of bone healing in the man and further therapeutic studies are required.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840730     DOI: 10.1007/bf02031617

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  MILKMAN'S SYNDROME SECONDARY TO PHOSPHATE DIABETES.

Authors:  R A HOUSTON; W A BRUSSOCK; H S CALLEN
Journal:  JAMA       Date:  1964-05-11       Impact factor: 56.272

2.  Peptiduria in an unusual bone disorder. Isolation of two peptides.

Authors:  J W SEAKINS
Journal:  Arch Dis Child       Date:  1963-06       Impact factor: 3.791

3.  A FACTOR DETERMINING THE LOCATION OF PSEUDOFRACTURES IN OSTEOMALACIA.

Authors:  M Le May; J W Blunt
Journal:  J Clin Invest       Date:  1949-05       Impact factor: 14.808

Review 4.  Progress in endocrinology and metabolism. Vitamin D: current concepts.

Authors:  L V Avioli; J G Haddad
Journal:  Metabolism       Date:  1973-03       Impact factor: 8.694

5.  Hereditary hyperphosphatasia. Studies of three siblings.

Authors:  R C Thompson; G E Gaull; S J Horwitz; R K Schenk
Journal:  Am J Med       Date:  1969-08       Impact factor: 4.965

6.  Familial hyperostosis of obscure nature.

Authors:  M Isaacs; E Scheiner; A B Dimich; G W Frimpter; E Greenberg; M H Alderman
Journal:  Metabolism       Date:  1971-10       Impact factor: 8.694

7.  Adult-onset vitamin-D-resistant hypophosphatemic osteomalacia. Effect of total parathyroidectomy.

Authors:  B L Riggs; R G Sprague; J Jowsey; F T Maher
Journal:  N Engl J Med       Date:  1969-10-02       Impact factor: 91.245

8.  The treatment of adult phosphate diabetes and Fanconi syndrome with neutral sodium phosphate.

Authors:  C Nagant de Deuxchaisnes; S M Krane
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

9.  Effect of vitamin D on in vitro bone calcium metabolism.

Authors:  W Y Au; F C Bartter
Journal:  Endocrinology       Date:  1966-06       Impact factor: 4.736

10.  25-hydroxycholecalciferol stimulation of muscle metabolism.

Authors:  S J Birge; J G Haddad
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.